Chloroquine Use For COVID-19 Shows No Benefit In First Small—But Limited—Controlled Trial

The study’s small size and other weaknesses mean it does not offer a lot of helpful information in determining the possible utility of hydroxychloroquine, according to experts who reviewed the study.

(Translated) ​ការប្រើ​ក្លូរ៉ូគីន​សម្រាប់​គម្រប ​- ២១ ​បង្ហាញ​ថា​មិន​មាន​អត្ថប្រយោជន៍​ទេ​ក្នុង​ការតូច​មួយ​ប៉ុន្តែ​មាន​កំណត់​ ​-​ ​ការជំនុំជម្រះ​ដែល​មាន​ការត្រួតពិនិត្យ​ ទំហំនៃការសិក្សានិងចំណុចខ្សោយផ្សេងទៀតមានន័យថាវាមិនផ្តល់នូវព័ត៌មានមានប្រយោជន៍ច្រើនក្នុងការកំណត់ថាតើអាចប្រើអ៊ីដ្រូហ្សីក្លូគីនបានទេ

Share Story

@ forbes.com16d ago749

Related Stories

Small Trial Finds No Evidence That Hydroxychloroquine Works Against Covid-19
A small trial from China may already throw into question whether a treatment touted as a way to save people with severe covid-19 can really work. It found no evidence that the existing drug hydroxychloroquine alone was more effective for patients


Recently Added Sites

Last updated: July 20, 2019
©2019 Prohok Solutions LLC·Home·Privacy·About